- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00839280
Moisturizing Effect of Two Dexpanthenol Formulations
October 14, 2014 updated by: Bayer
Evaluation of the Moisturizing Effect of Bepanthen Burn Relief Foam Spray New Formula Versus Bepanthen Burn Relief Foam Spray (Current Formula). Equivalence Trial. Intra-individual Design.
The study focuses to prove the equivalent moisturizing effect of two different Dexpanthenol formulations
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
19
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Villeurbanne, France, 69503
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 63 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Healthy subjects
- Phototype: I to IV according to Fitzpatrick scale
- Subjects with dry skin on their forearms
Exclusion Criteria:
- Pregnant or nursing women
- Subjects registered as being in exclusion period in the French Health Minister file of subjects
- Subjects with hypersensitivity to one of the test products
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Arm 2
|
2 applications of 2 micro liter/square centimeter on a 4X4 cm area corresponding to 32 micro liter
|
Experimental: Arm 1
|
2 applications of 2 micro liter/square centimeter on a 4X4 cm area corresponding to 32 micro liter
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Area Under Curve (AUC) of the cutaneous hydration rate measured with corneometer between T0 and T5h
Time Frame: 0 min, 15 min, 30 min, 1h, 2h, 3h, 5h
|
0 min, 15 min, 30 min, 1h, 2h, 3h, 5h
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Cutaneous hydration rate
Time Frame: 15 min, 30 min, 1h, 2h, 3h, 5h
|
15 min, 30 min, 1h, 2h, 3h, 5h
|
Incidence of Adverse Events
Time Frame: FPFV - LPLV
|
FPFV - LPLV
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2007
Primary Completion (Actual)
September 1, 2007
Study Completion (Actual)
September 1, 2007
Study Registration Dates
First Submitted
February 6, 2009
First Submitted That Met QC Criteria
February 6, 2009
First Posted (Estimate)
February 9, 2009
Study Record Updates
Last Update Posted (Estimate)
October 15, 2014
Last Update Submitted That Met QC Criteria
October 14, 2014
Last Verified
October 1, 2014
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 12040
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Skin Abnormalities
-
Enspectra HealthNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedSkin Diseases | Skin Abnormalities | Skin Cancer | Skin Lesion | Skin ConditionUnited States
-
Enspectra HealthNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedSkin Diseases | Skin Abnormalities | Skin Cancer | Skin Lesion | Skin ConditionUnited States
-
Hillel Yaffe Medical CenterUnknown
-
Avita MedicalBiomedical Advanced Research and Development AuthorityTerminatedSkin; DeformityUnited States
-
Coloplast A/SRecruiting
-
Integrative Skin Science and ResearchArbonneCompleted
-
HealthpointTerminatedSkin AbnormalitiesUnited States
-
Let's DiscoCitruslabsCompletedSkin Abnormalities | AcneUnited States
-
Centre Hospitalier Departemental VendeeCompleted
Clinical Trials on Dexpanthenol foam spray, new formulation
-
GenfitNaturalpha; SGS Aster S.A.S.CompletedCardiovascular Diseases | Metabolic Diseases | Diabetes Mellitus, Type 2 | Type 2 Diabetes | Dyslipidemia | ObeseFrance
-
GlaxoSmithKlineCompletedSubstance DependenceUnited Kingdom
-
The Netherlands Cancer InstituteCompleted
-
LEO PharmaBayerCompleted
-
TakedaCompleted
-
LEO PharmaBayerCompleted
-
GlaxoSmithKlineCompleted
-
Boehringer IngelheimTerminated